215 related articles for article (PubMed ID: 38344872)
1. NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.
Mendiburu-Eliçabe M; García-Sancha N; Corchado-Cobos R; Martínez-López A; Chang H; Hua Mao J; Blanco-Gómez A; García-Casas A; Castellanos-Martín A; Salvador N; Jiménez-Navas A; Pérez-Baena MJ; Sánchez-Martín MA; Abad-Hernández MDM; Carmen SD; Claros-Ampuero J; Cruz-Hernández JJ; Rodríguez-Sánchez CA; García-Cenador MB; García-Criado FJ; Vicente RS; Castillo-Lluva S; Pérez-Losada J
Clin Transl Med; 2024 Feb; 14(2):e1554. PubMed ID: 38344872
[TBL] [Abstract][Full Text] [Related]
2. NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence.
Mendiburu-Eliçabe M; García-Sancha N; Corchado-Cobos R; Martínez-López A; Chang H; Mao JH; Blanco-Gómez A; García-Casas A; Castellanos-Martín A; Salvador N; Jiménez-Navas A; Pérez-Baena MJ; Sánchez-Martín MA; Abad-Hernández MDM; Del Carmen S; Claros-Ampuero J; Cruz-Hernández JJ; Rodríguez-Sánchez CA; García-Cenador MB; García-Criado FJ; Vicente RS; Castillo-Lluva S; Pérez-Losada J
Res Sq; 2023 Oct; ():. PubMed ID: 37886490
[TBL] [Abstract][Full Text] [Related]
3. Identification of NCAPH as a biomarker for prognosis of breast cancer.
Lu H; Shi C; Wang S; Yang C; Wan X; Luo Y; Tian L; Li L
Mol Biol Rep; 2020 Oct; 47(10):7831-7842. PubMed ID: 33009967
[TBL] [Abstract][Full Text] [Related]
4. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
Ogura T; Azuma K; Sato J; Kinowaki K; Takayama KI; Takeiwa T; Kawabata H; Inoue S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768935
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cycle stage critically affects 21-gene recurrence scores in Mmtv-Pymt mouse mammary tumours.
Bernhardt SM; Dasari P; Glynn DJ; Woolford L; Moldenhauer LM; Walsh D; Townsend AR; Price TJ; Ingman WV
BMC Cancer; 2021 Jun; 21(1):736. PubMed ID: 34174867
[TBL] [Abstract][Full Text] [Related]
6. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
[TBL] [Abstract][Full Text] [Related]
7. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
Wang M; Qiao X; Cooper T; Pan W; Liu L; Hayball J; Lin J; Cui X; Zhou Y; Zhang S; Zou Y; Zhang R; Wang X
Cell Death Dis; 2020 Dec; 11(12):1049. PubMed ID: 33311486
[TBL] [Abstract][Full Text] [Related]
8. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
Qiu X; Gao Z; Shao J; Li H
Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
[TBL] [Abstract][Full Text] [Related]
9. Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Buus R; Yeo B; Brentnall AR; Klintman M; Cheang MCU; Khabra K; Sestak I; Gao Q; Cuzick J; Dowsett M
Breast Cancer Res; 2018 Sep; 20(1):103. PubMed ID: 30180877
[TBL] [Abstract][Full Text] [Related]
10. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
11. NCAPH regulates gastric cancer progression through DNA damage response.
Wang Y; Li JQ; Yang ZL; Wang L; Zhang JC; Sun YF; Li ZY; Qin L
Neoplasma; 2022 Mar; 69(2):283-291. PubMed ID: 34962823
[TBL] [Abstract][Full Text] [Related]
12. A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer.
Chiodoni C; Sangaletti S; Lecchi M; Ciniselli CM; Cancila V; Tripodi I; Ratti C; Talarico G; Brich S; De Cecco L; Baili P; Truffi M; Sottotetti F; Piccotti F; Tripodo C; Pruneri G; Triulzi T; Corsi F; Cappelletti V; Di Cosimo S; Verderio P; Colombo MP
ESMO Open; 2023 Aug; 8(4):101590. PubMed ID: 37393630
[TBL] [Abstract][Full Text] [Related]
13. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.
Li B; Xiao Q; Shan L; Song Y
Cell Cycle; 2022 Feb; 21(4):427-438. PubMed ID: 34974790
[TBL] [Abstract][Full Text] [Related]
14. An integrative pan-cancer analysis reveals the carcinogenic effects of NCAPH in human cancer.
Liu Y; Ma X; Feng L; Lin Z; Zhou X
Math Biosci Eng; 2023 Jan; 20(1):76-92. PubMed ID: 36650758
[TBL] [Abstract][Full Text] [Related]
15. NCAPH Is Required for Proliferation, Migration and Invasion of Non-small-cell Lung Cancer Cells.
Kim B; Kim SW; Lim JY; Park SJ
Anticancer Res; 2020 Jun; 40(6):3239-3246. PubMed ID: 32487618
[TBL] [Abstract][Full Text] [Related]
16. Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
Int J Urol; 2019 Apr; 26(4):506-520. PubMed ID: 30818424
[TBL] [Abstract][Full Text] [Related]
17. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
18. Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer.
Kelly CM; Bernard PS; Krishnamurthy S; Wang B; Ebbert MT; Bastien RR; Boucher KM; Young E; Iwamoto T; Pusztai L
Oncologist; 2012; 17(4):492-8. PubMed ID: 22418568
[TBL] [Abstract][Full Text] [Related]
19. A novel epigenetic signature for overall survival prediction in patients with breast cancer.
Bao X; Anastasov N; Wang Y; Rosemann M
J Transl Med; 2019 Nov; 17(1):380. PubMed ID: 31747912
[TBL] [Abstract][Full Text] [Related]
20. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
